BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 856 filers reported holding BAXTER INTL INC in Q2 2024. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $235 | -24.2% | 6,964 | -3.3% | 0.01% | -27.8% |
| Q1 2024 | $310 | +11.9% | 7,201 | +1.4% | 0.02% | 0.0% |
| Q4 2023 | $277 | -1.8% | 7,101 | -4.1% | 0.02% | -10.0% |
| Q3 2023 | $282 | -40.6% | 7,401 | -28.5% | 0.02% | -37.5% |
| Q2 2023 | $475 | -2.3% | 10,350 | -13.0% | 0.03% | -8.6% |
| Q1 2023 | $486 | -21.0% | 11,900 | -0.8% | 0.04% | -23.9% |
| Q4 2022 | $615 | -99.9% | 11,995 | 0.0% | 0.05% | -11.5% |
| Q3 2022 | $650,000 | -20.9% | 11,995 | -5.9% | 0.05% | -17.5% |
| Q2 2022 | $822,000 | -17.1% | 12,744 | 0.0% | 0.06% | -7.4% |
| Q1 2022 | $992,000 | -8.9% | 12,744 | +0.8% | 0.07% | -5.6% |
| Q4 2021 | $1,089,000 | +7.2% | 12,644 | +0.4% | 0.07% | -5.3% |
| Q3 2021 | $1,016,000 | -7.3% | 12,592 | -2.8% | 0.08% | -14.6% |
| Q2 2021 | $1,096,000 | 0.0% | 12,954 | 0.0% | 0.09% | 0.0% |
| Q1 2021 | $1,096,000 | +5.1% | 12,954 | 0.0% | 0.09% | -1.1% |
| Q4 2020 | $1,043,000 | -0.2% | 12,954 | 0.0% | 0.09% | -1.1% |
| Q3 2020 | $1,045,000 | -6.6% | 12,954 | 0.0% | 0.09% | -16.5% |
| Q2 2020 | $1,119,000 | +5.3% | 12,954 | -0.8% | 0.11% | -11.4% |
| Q1 2020 | $1,063,000 | -5.1% | 13,055 | -2.2% | 0.12% | +17.1% |
| Q4 2019 | $1,120,000 | -4.4% | 13,355 | 0.0% | 0.10% | -12.5% |
| Q3 2019 | $1,171,000 | +6.7% | 13,355 | 0.0% | 0.12% | +4.3% |
| Q2 2019 | $1,097,000 | +0.3% | 13,355 | -0.6% | 0.12% | -5.7% |
| Q1 2019 | $1,094,000 | +22.1% | 13,429 | -1.1% | 0.12% | +8.0% |
| Q4 2018 | $896,000 | -14.6% | 13,578 | 0.0% | 0.11% | 0.0% |
| Q3 2018 | $1,049,000 | +4.4% | 13,578 | 0.0% | 0.11% | -0.9% |
| Q2 2018 | $1,005,000 | +13.6% | 13,578 | 0.0% | 0.11% | +10.7% |
| Q1 2018 | $885,000 | +0.8% | 13,578 | 0.0% | 0.10% | 0.0% |
| Q4 2017 | $878,000 | +3.7% | 13,578 | +0.5% | 0.10% | -1.9% |
| Q3 2017 | $847,000 | +3.5% | 13,504 | 0.0% | 0.10% | +1.0% |
| Q2 2017 | $818,000 | +16.9% | 13,504 | 0.0% | 0.10% | +15.6% |
| Q1 2017 | $700,000 | -44.6% | 13,504 | -52.6% | 0.09% | +3.4% |
| Q4 2016 | $1,264,000 | +86.4% | 28,508 | +100.0% | 0.09% | -13.0% |
| Q3 2016 | $678,000 | +5.1% | 14,254 | 0.0% | 0.10% | +5.3% |
| Q2 2016 | $645,000 | +6.3% | 14,254 | -3.6% | 0.10% | +4.4% |
| Q1 2016 | $607,000 | +7.8% | 14,782 | +0.2% | 0.09% | +9.6% |
| Q4 2015 | $563,000 | +16.1% | 14,754 | 0.0% | 0.08% | +7.8% |
| Q3 2015 | $485,000 | -57.1% | 14,754 | -8.7% | 0.08% | -56.0% |
| Q2 2015 | $1,130,000 | +7.4% | 16,163 | +5.2% | 0.18% | +10.1% |
| Q1 2015 | $1,052,000 | -3.4% | 15,363 | +3.4% | 0.16% | -5.4% |
| Q4 2014 | $1,089,000 | -15.1% | 14,863 | -16.8% | 0.17% | -17.6% |
| Q3 2014 | $1,282,000 | -0.8% | 17,863 | 0.0% | 0.20% | 0.0% |
| Q2 2014 | $1,292,000 | -1.7% | 17,863 | -0.0% | 0.20% | -6.8% |
| Q1 2014 | $1,314,000 | +7.1% | 17,867 | +1.3% | 0.22% | +5.8% |
| Q4 2013 | $1,227,000 | +6.4% | 17,635 | +0.4% | 0.21% | 0.0% |
| Q3 2013 | $1,153,000 | -4.8% | 17,558 | +0.4% | 0.21% | -8.0% |
| Q2 2013 | $1,211,000 | +30.5% | 17,483 | -10.1% | 0.22% | -4.7% |
| Q3 2010 | $928,000 | +15.6% | 19,448 | -1.6% | 0.24% | +12.4% |
| Q2 2010 | $803,000 | – | 19,758 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 16,850,000 | $1,473,870,000 | 17.51% |
| SECTOR GAMMA AS | 472,305 | $41,313,000 | 6.98% |
| TSFG, LLC | 91,132 | $7,971,000 | 6.10% |
| Veritas Asset Management LLP | 6,386,849 | $558,658,000 | 5.44% |
| Palmer Knight Co | 64,636 | $5,654,000 | 4.80% |
| Triodos Investment Management BV | 193,700 | $16,943,000 | 4.30% |
| Progressive Investment Management Corp | 82,216 | $7,191,000 | 3.85% |
| Alphinity Investment Management Pty Ltd | 362,173 | $31,679,000 | 3.65% |
| HealthCor Management, L.P. | 1,032,820 | $90,341,000 | 3.42% |
| Sivik Global Healthcare LLC | 75,000 | $6,560,000 | 3.31% |